| __timestamp | Ionis Pharmaceuticals, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 85181000 |
| Thursday, January 1, 2015 | 322292000 | 135253000 |
| Friday, January 1, 2016 | 344320000 | 162297000 |
| Sunday, January 1, 2017 | 374644000 | 198442000 |
| Monday, January 1, 2018 | 414604000 | 226616000 |
| Tuesday, January 1, 2019 | 466000000 | 299726000 |
| Wednesday, January 1, 2020 | 535000000 | 335375000 |
| Friday, January 1, 2021 | 643000000 | 505748000 |
| Saturday, January 1, 2022 | 833000000 | 590453000 |
| Sunday, January 1, 2023 | 899625000 | 849658000 |
| Monday, January 1, 2024 | 901530000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Jazz Pharmaceuticals plc and Ionis Pharmaceuticals, Inc. have been at the forefront of this race, investing heavily in R&D to bring groundbreaking therapies to market.
From 2014 to 2023, Ionis Pharmaceuticals has consistently outpaced Jazz Pharmaceuticals in R&D spending. Ionis increased its investment by nearly 272%, peaking in 2023 with a staggering 900 million USD. Jazz Pharmaceuticals, while starting with a modest 85 million USD in 2014, ramped up its R&D budget by almost 900% to reach 850 million USD in 2023.
These investments underscore a commitment to innovation, with both companies striving to develop novel treatments. As the pharmaceutical landscape evolves, such strategic investments are crucial for maintaining a competitive edge and delivering life-changing therapies.
Comparing Innovation Spending: Eli Lilly and Company and Ionis Pharmaceuticals, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
R&D Insights: How Jazz Pharmaceuticals plc and Ultragenyx Pharmaceutical Inc. Allocate Funds
Research and Development Investment: Jazz Pharmaceuticals plc vs Pharming Group N.V.
Comparing Innovation Spending: Jazz Pharmaceuticals plc and MorphoSys AG
Research and Development Investment: Jazz Pharmaceuticals plc vs HUTCHMED (China) Limited
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Geron Corporation
R&D Insights: How Jazz Pharmaceuticals plc and Taro Pharmaceutical Industries Ltd. Allocate Funds
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated